相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
452342-67-5
- 规格:
10 mM * 1 mL/5 mg/10 mg/50 mg/100 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥671.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥610.0 |
| 规格: | 10 mg | 产品价格: | ¥990.0 |
| 规格: | 50 mg | 产品价格: | ¥3100.0 |
| 规格: | 100 mg | 产品价格: | ¥5200.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
GW788388
CAS No. : 452342-67-5
MCE 国际站:GW788388
产品活性:GW788388 是一种有效的 ALK5 抑制剂,IC50 值 18 nM;同时抑制 TGF-β II 型受体 和激活素 II 型受体的活性,但对 BMP II 型受体无作用。
研究领域:TGF-beta/Smad
作用靶点:TGF-β Receptor
In Vivo: GW788388 given orally for 5 weeks significantly reduces renal fibrosis and decreased the mRNA levels of key mediators of extracellular matrix deposition in kidneys in db/db mice. GW788388 (50 mg/kg/day, p.o.) significantly attenuates systolic dysfunction in the MI animals, together with the attenuation of the activated (phosphorylated) Smad2 (P < 0.01), α-smooth muscle actin (P < 0.001), and collagen I (P < 0.05) in the noninfarct zone of MI rats. GW788388 reduces the expression of collagen IA1 by 80% at a dose of 1 mg/kg twice a day (b.i.d.). GW788388 significantly reduces the expression of collagen IA1 mRNA when administered orally at 10 mg/kg once a day (u.i.d.) in a model of puromycin aminonucleoside-induced renal fibrosis.
相关产品:Covalent Screening Library Plus | Bioactive Compound Library Plus | Kinase Inhibitor Library | TGF-beta/Smad Compound Library | Anti-Cancer Compound Library | Covalent Screening Library | Reprogramming Compound Library | Chemical Probe Library | Anti-Pancreatic Cancer Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Anti-Colorectal Cancer Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Osteogenesis Compound Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Cytokine Inhibitors Library | SB-431542 | Dorsomorphin | A 83-01 | Galunisertib | LDN193189 | RepSox | LY2109761 | DMH-1 | SB 525334 | Vactosertib | BMP signaling agonist sb4 | LY-364947 | SB-505124 | LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA) | ITD-1 | LDN-212854 | LY3200882 | Bimagrumab | ML347 | SD-208 | K02288 | Fresolimumab | IN-1130 | LDN-214117 | R-268712
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验magichunter 我在文献中查到,PPARr拮抗剂GW9662可以抑制药物的抗炎作用,前提是药物是通过激活PPARr来实现其抗炎作用的。即炎症细胞中的炎症因子(如:NO)升高,加入抗炎药物后,NO水平降低,当同时给予GW9662和该抗炎药物时,该药物的抗炎作用被抑制,NO水平再次升高。以上是文献的报道,但是我在实验时发现,加入了抗炎药物+GW9662后,NO的水平不但没有升高,反而降低了(与单独抗炎药物组相比),不知这是怎么回事? chp
. A new drug candidate belonging to the family of the peroxisome proliferator-activated receptor-delta agonists termed GW1516 (also referred to as GW501516) has been prohibited by the World Anti-Doping Agency in 2009
有一种胖,反而有利于心血管健康!「肥胖悖论」新证据,源于脂肪
-HFD 喂养的 adipo-FtMT 小鼠心脏组织的蛋白质羰基化水平显著升高,且线粒体 H2O2 产生水平较对照小鼠显著增加。研究者根据这些数据提出大胆假设,即体内存在一种内分泌机制将促氧化信号从脂肪细胞传递到心肌。接下来,研究者通过纳米粒子追踪分析测量,发现食用 dox-HFD 3 周的 Adipo-FtMT 小鼠的循环 sEV 水平显著升高。进一步,利用中性鞘磷脂酶抑制剂 GW4869 阻断外泌体的产生,实验结果表明 dox-HFD 喂食 4 小时后,GW4869 完全阻止了 adipo
技术资料暂无技术资料 索取技术资料

















